Discover how MHY218, a new HDAC inhibitor, fights tamoxifen-resistant breast cancer by triggering dual cell death pathways through epigenetic reprogramming.
Discover how prolactin, estrogen and prolidase interact in breast cancer cells and how this knowledge could lead to better treatments.
Exploring how Conjugated Linoleic Acid (CLA) may help fight breast cancer by disrupting cancer cells' fat production pathways.